<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02898025</url>
  </required_header>
  <id_info>
    <org_study_id>RLiebano</org_study_id>
    <nct_id>NCT02898025</nct_id>
  </id_info>
  <brief_title>Low Level Laser Therapy and Interferential Current in Osteoarthritis</brief_title>
  <official_title>Low Level Laser Therapy and Interferential Current in Patients With Knee Osteoarthritis: Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Cidade de Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Cidade de Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the effectiveness of the low level laser therapy and&#xD;
      interferential current in 168 patients with knee osteoarthritis&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Interventional&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity measured by a numeric pain scale ranging from 0 to 10.</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pressure Pain Threshold measured by a pressure algometer. Pressure will be recorded in kPa.</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>TUG (Timed Up &amp; Go Test)</measure>
    <time_frame>Measure at baseline, 4 weeks, 3 months, 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Isokinetic Muscle Assessment</measure>
    <time_frame>Measure at baseline, 4 weeks, 3 months, 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LeQuesne Questionnaire</measure>
    <time_frame>Measure at baseline, 4 weeks, 3 months, 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WOMAC (Western Ontario and McMaster Universities Arthritis Index)</measure>
    <time_frame>Measure at baseline, 4 weeks, 3 months, 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">168</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>G1 (Active IFC and Active Laser)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>42 patients with knee (s) osteoarthritis. All patients will receive guidance on the disease and on joint protection and energy conservation over a period of 50 minutes in a single session. This group (G1) will receive the treatment of Active Interferential Current and Active Laser for 12 sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>G2 (Active IFC and Placebo Laser)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>42 patients with knee (s) osteoarthritis. All patients will receive guidance on the disease and on joint protection and energy conservation over a period of 50 minutes in a single session. This group (G2) will receive the treatment of Active Interferential Current and Placebo Laser for 12 sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>G3 (Placebo IFC and Active Laser)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>42 patients with knee (s) osteoarthritis. All patients will receive guidance on the disease and on joint protection and energy conservation over a period of 50 minutes in a single session. This group (G3) will receive Placebo Interferential Current and Active Laser for 12 sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>G4 (Placebo IFC and Placebo Laser)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>42 patients with knee (s) osteoarthritis. All patients will receive guidance on the disease and on joint protection and energy conservation over a period of 50 minutes in a single session. The placebo group (G4) will receive Placebo Interferential Current and Placebo Laser for 12 sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active Interferential Current</intervention_name>
    <description>Involves the application of medium frequency alternating currents</description>
    <arm_group_label>G1 (Active IFC and Active Laser)</arm_group_label>
    <arm_group_label>G2 (Active IFC and Placebo Laser)</arm_group_label>
    <other_name>interferential therapy</other_name>
    <other_name>IFC</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active Laser</intervention_name>
    <description>Involves the application of low level laser over the knee</description>
    <arm_group_label>G1 (Active IFC and Active Laser)</arm_group_label>
    <arm_group_label>G3 (Placebo IFC and Active Laser)</arm_group_label>
    <other_name>low level laser therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo Interferential Current</intervention_name>
    <description>It is a sham interferential therapy</description>
    <arm_group_label>G3 (Placebo IFC and Active Laser)</arm_group_label>
    <arm_group_label>G4 (Placebo IFC and Placebo Laser)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo Laser</intervention_name>
    <description>It is a sham laser therapy</description>
    <arm_group_label>G2 (Active IFC and Placebo Laser)</arm_group_label>
    <arm_group_label>G4 (Placebo IFC and Placebo Laser)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  History of osteoarthritis of the knee characterized by pain of mild or moderate&#xD;
             intensity&#xD;
&#xD;
          -  Radiographic evidence of grade 2 or 3 osteoarthritis based on the Kellgren and&#xD;
             Lawrence radiographic entry criteria&#xD;
&#xD;
          -  Patients with knee osteoarthritis (s) according to the ACR criteria&#xD;
&#xD;
          -  VAS 3 to 8&#xD;
&#xD;
          -  5 to 12 Lequesne&#xD;
&#xD;
          -  No complaint of pain in other joints of the lower limbs&#xD;
&#xD;
          -  Without neurological and cognitive disorders&#xD;
&#xD;
          -  No loss of sensation in the lower limbs&#xD;
&#xD;
          -  No surgery on the knee (s) in the last 6 months&#xD;
&#xD;
          -  Pain symptoms for at least 6 months&#xD;
&#xD;
          -  No infiltrations (s) knee (s) in the last 4 weeks&#xD;
&#xD;
          -  No use of analgesics 4 hours before treatment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals younger than 18 and older than 80 years&#xD;
&#xD;
          -  Complaints from other diseases of the lower limbs, knee prosthesis and / or hip joint&#xD;
             instabilities and / or surgery in lower limbs, heart disease, uncontrolled&#xD;
             hypertension and diabetes, coagulation disorders in anticoagulant therapy, pregnant&#xD;
             women, fibromyalgia and individuals who can not perform isokinetic test who have&#xD;
             difficulty performing the TUG, and those that are experiencing abnormal sensitivity to&#xD;
             algometry&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard E Liebano, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Cidade de Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UNICID</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>03071-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>April 20, 2016</study_first_submitted>
  <study_first_submitted_qc>September 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2016</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Cidade de Sao Paulo</investigator_affiliation>
    <investigator_full_name>Richard Eloin Liebano</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

